These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae.
    Author: Traub WH, Leonhard B.
    Journal: Chemotherapy; 1996; 42(4):240-7. PubMed ID: 8804790.
    Abstract:
    Ninety-three representative, recent clinical isolates of Streptococcus pneumoniae were examined for susceptibility to 9 antimicrobial drugs utilizing Mueller-Hinton agar (MHA) enriched with sheep blood and a hypercapnic atmosphere of incubation. One isolate was resistant to penicillin G (minimum inhibitory concentration, MIC = 2 micrograms/ml) and 6 isolates were of intermediate susceptibility to penicillin G (MICs = 0.125-0.25 microgram/ml). The penicillin-G-resistant isolate was also resistant to cefuroxime (MIC = 4 micrograms/ml) and of intermediate susceptibility to cefotaxime (MIC = 1 microgram/ml). This isolate was resistant to chloramphenicol (MIC = 16 micrograms/ml) as well. All 93 isolates were susceptible to teicoplanin and vancomycin. Two isolates each were resistant (MICs = 16 micrograms/ml) or moderately susceptible (MICs = 8 micrograms/ml) to chloramphenicol. Eight isolates were resistant to doxycycline (MICs > or = 8 micrograms/ml), whereas 2 isolates were of intermediate susceptibility to this antibiotic (MICs = 4 micrograms/ml). Three isolates were resistant to erythromycin (MICs > or = 4 micrograms/ml), and 2 isolates showed reduced susceptibility to erythromycin (MICs = 2 micrograms/ml). Chocolatized MHA antagonized the activity of teicoplanin and vancomycin against pneumococcal isolates. Haemophilus test and Wilkins-Chalgren media failed to support optimal growth of all pneumococcal isolates.
    [Abstract] [Full Text] [Related] [New Search]